Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 850349-22-3 | MDL No. : | MFCD08706083 |
Formula : | C7H8BrN3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | OOQMJOASAODMEW-UHFFFAOYSA-N |
M.W : | 214.06 | Pubchem ID : | 17749937 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.43 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 49.57 |
TPSA : | 29.02 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.55 cm/s |
Log Po/w (iLOGP) : | 2.22 |
Log Po/w (XLOGP3) : | 1.48 |
Log Po/w (WLOGP) : | 1.07 |
Log Po/w (MLOGP) : | 1.18 |
Log Po/w (SILICOS-IT) : | 1.78 |
Consensus Log Po/w : | 1.55 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.44 |
Solubility : | 0.782 mg/ml ; 0.00365 mol/l |
Class : | Soluble |
Log S (Ali) : | -1.7 |
Solubility : | 4.31 mg/ml ; 0.0201 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.68 |
Solubility : | 0.449 mg/ml ; 0.0021 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.76 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
[ 887433-64-9 ]
N1-(5-Bromopyrimidin-2-yl)-N2,N2-dimethylethane-1,2-diamine
Similarity: 0.86
[ 887425-47-0 ]
1-(5-Bromopyrimidin-2-yl)piperidin-4-ol
Similarity: 0.86
[ 77476-95-0 ]
(5-Bromopyrimidin-2-yl)isopropylamine
Similarity: 0.85
[ 38696-21-8 ]
5-Bromo-N,N-dimethylpyrimidin-2-amine
Similarity: 0.84
[ 914347-70-9 ]
1-(5-Bromopyrimidin-2-yl)-3-pyrrolidinol
Similarity: 0.84
[ 2044704-96-1 ]
2-(4-(Azetidin-3-yl)piperazin-1-yl)pyrimidine hydrochloride
Similarity: 0.72
[ 1411643-59-8 ]
(2-(Azetidin-1-yl)pyrimidin-5-yl)boronic acid
Similarity: 0.59
[ 887433-64-9 ]
N1-(5-Bromopyrimidin-2-yl)-N2,N2-dimethylethane-1,2-diamine
Similarity: 0.86
[ 887425-47-0 ]
1-(5-Bromopyrimidin-2-yl)piperidin-4-ol
Similarity: 0.86
[ 77476-95-0 ]
(5-Bromopyrimidin-2-yl)isopropylamine
Similarity: 0.85
[ 38696-21-8 ]
5-Bromo-N,N-dimethylpyrimidin-2-amine
Similarity: 0.84
[ 914347-70-9 ]
1-(5-Bromopyrimidin-2-yl)-3-pyrrolidinol
Similarity: 0.84